Campbell’s (NASDAQ:CPB – Get Free Report) had its target price cut by equities research analysts at Morgan Stanley from $30.00 to $28.00 in a research report issued on Friday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s price target suggests a potential upside of 4.09% from the stock’s current price.
A number of other equities research analysts have also commented on the stock. Stephens lowered their price target on shares of Campbell’s from $40.00 to $38.00 and set an “overweight” rating for the company in a report on Monday, December 8th. Weiss Ratings lowered shares of Campbell’s from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, January 5th. UBS Group reduced their price target on Campbell’s from $28.00 to $26.00 and set a “sell” rating on the stock in a report on Wednesday, December 10th. Wells Fargo & Company decreased their price target on shares of Campbell’s from $31.00 to $30.00 and set an “equal weight” rating for the company in a research note on Wednesday, December 10th. Finally, Sanford C. Bernstein cut their price objective on Campbell’s from $39.00 to $33.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 10th. Three equities research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and six have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average price target of $32.47.
Get Our Latest Analysis on Campbell’s
Campbell’s Price Performance
Campbell’s (NASDAQ:CPB – Get Free Report) last posted its quarterly earnings results on Tuesday, December 9th. The company reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.73 by $0.04. Campbell’s had a return on equity of 21.84% and a net margin of 5.69%.The business had revenue of $2.68 billion for the quarter. The business’s revenue for the quarter was down 3.4% on a year-over-year basis. Campbell’s has set its FY 2026 guidance at 2.400-2.550 EPS. Equities research analysts expect that Campbell’s will post 3.15 EPS for the current year.
Insider Activity
In related news, EVP Charles A. Brawley III sold 11,550 shares of the firm’s stock in a transaction that occurred on Tuesday, December 30th. The shares were sold at an average price of $28.14, for a total transaction of $325,017.00. Following the completion of the sale, the executive vice president owned 43,777 shares of the company’s stock, valued at $1,231,884.78. This trade represents a 20.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Anthony Sanzio sold 2,700 shares of the company’s stock in a transaction that occurred on Friday, January 9th. The shares were sold at an average price of $26.51, for a total value of $71,577.00. Following the completion of the transaction, the executive vice president directly owned 25,264 shares in the company, valued at $669,748.64. This trade represents a 9.66% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 19.78% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the business. Ameritas Advisory Services LLC bought a new position in shares of Campbell’s during the second quarter valued at $25,000. Stance Capital LLC bought a new position in Campbell’s during the 3rd quarter valued at about $27,000. ORG Partners LLC lifted its stake in Campbell’s by 77.3% during the 2nd quarter. ORG Partners LLC now owns 906 shares of the company’s stock valued at $29,000 after acquiring an additional 395 shares during the period. SBI Securities Co. Ltd. boosted its holdings in Campbell’s by 66.8% in the second quarter. SBI Securities Co. Ltd. now owns 961 shares of the company’s stock worth $29,000 after purchasing an additional 385 shares during the last quarter. Finally, Geneos Wealth Management Inc. grew its position in Campbell’s by 333.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 975 shares of the company’s stock worth $39,000 after purchasing an additional 750 shares during the period. Hedge funds and other institutional investors own 52.35% of the company’s stock.
Campbell’s Company Profile
Campbell’s (NASDAQ: CPB) is a leading manufacturer of shelf-stable foods and beverages, best known for its iconic soups and broths. Headquartered in Camden, New Jersey, the company offers a diverse portfolio of products designed to meet consumer demand for convenient, affordable meals and snacks. Since its founding in 1869, Campbell’s has grown through a combination of organic innovation and strategic acquisitions to expand its presence in the food industry.
The company’s brand portfolio includes Campbell’s Condensed Soups, V8 juices, Prego pasta sauces, Swanson broths and stocks, Pace salsas and dips, and Pepperidge Farm baked snacks.
Read More
- Five stocks we like better than Campbell’s
- Buy Alert: $8 AI Stock
- 53% Gains In 4 Years. Then 51% In Under 11 Months.
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
Receive News & Ratings for Campbell's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Campbell's and related companies with MarketBeat.com's FREE daily email newsletter.
